Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_assertion type Assertion NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_head.
- NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_assertion description "[So far the value of conventional tumour markers such as Ca72-4 or carcinoembryonic antigen is limited, and even markers developed from molecular biological studies on the carcinogenesis of gastric cancer, such as E-cadherin and others, have not proved to be of adequate sensitivity and specificity to allow the early detection of gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_provenance.
- NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_assertion evidence source_evidence_literature NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_provenance.
- NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_assertion SIO_000772 16825900 NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_provenance.
- NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_assertion wasDerivedFrom befree-20140225 NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_provenance.
- NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_assertion wasGeneratedBy ECO_0000203 NP511592.RAZq3amfI_T6DXxD8kgXFG7tJfr-yGpIcv9sPxXPflmPE130_provenance.